CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 24 No. 14
INTEGRATIVE ONCOLOGY 

Lycium (Lycium barbarum)

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | January 4, 2011
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Lycium (Lycium barbarum)

ALSO KNOWN AS: Gou qi zi, goji, gochi, wolfberry, lycium fruit, bastard jasmine, box thorn, tea tree, matrimony vine.

SUMMARY: The berries of Lyciumpic barbarum, a perennial plant native to Asia and southeastern Europe, have been used for centuries in traditional Chinese medicine to treat poor vision, anemia, inflammation, and cough. They are also consumed as food and used in soup recipes.

Lycium has gained immense popularity in the United States over the past decade because of its antioxidant properties. It is available in health food stores and is marketed via the Internet in juice form, typically blended with the juices of other berries and fruits. A wide range of health benefits, including cancer prevention and treatment, have been claimed for lycium.

RESEARCH: The bulk of the data on lycium is from in vitro and animal studies. Human data are limited to observational studies. No clinical trials to validate lycium as a cancer treatment have been conducted.

In vitro studies show that a polysaccharide isolated from lycium has antitumor,[1] immune enhancing,[2] hepatoprotective,[3] and neuroprotective[4] properties. It also had radiosensitizing[5] and photoprotective[6] effects in mice, and lycium reduced cardiotoxicity associated with doxorubicin(Drug information on doxorubicin) in an animal model.[7]

In addition, lycium inhibited the growth of estrogen receptor–positive breast cancer cells.[8] Small studies of lycium reported subjective improvement in well-being in healthy subjects.[9-11] Data from an observational study of 75 patients conducted in Take HomeChina showed that polysaccharides from lycium taken orally resulted in cancer regression when used with lymphokine-activated killer cells/interleukin 2 (LAK/IL2), an experimental treatment.[12] Lycium’s anticancer potential, however, remains unknown.

HERB-DRUG INTERACTIONS: Warfarin(Drug information on warfarin). Two cases of an elevated international normalized ratio following consumption of concentrated Chinese herbal tea made from lycium have been reported in patients receiving anticoagulant therapy.[13,14]

COMMENTS: Lycium has not been subjected to rigorous clinical trials. Despite the lack of substantial scientific evidence, lycium-containing juices are marketed as cancer cures. Many brands do not indicate the amount of lycium present in the products.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES

1. Zhang Z, Liu X, Wu T, et al. Selective suppression of cervical cancer Hela cells by 2-O-beta-D: -glucopyranosyl-L: -ascorbic acid isolated from the fruit of Lycium barbarum L. Cell Biol Toxicol. 2010 Aug 19. [Epub ahead of print]

2. Gan L, Zhang SH, Liu Q, Xu HB. A polysaccharide-protein complex from Lycium barbarum upregulates cytokine expression in human peripheral blood mononuclear cells. Eur J Pharmacol. 2003;471:217-22.

3. Kim SY, Lee EJ, Kim HP, Lee HS, Kim YC. LCC, a cerebroside from Lycium chinense, protects primary cultured rat hepatocytes exposed to galactosamine. Phytother Res 2000;14:448-51.

4. Ho YS, Yu MS, Yang XF, et al. Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons. J Alzheimers Dis. 2010;19:813-27.

5. Lu CX,.Cheng BQ. [Radiosensitizing effects of Lycium barbarum polysaccharide for Lewis lung cancer]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1991;11:611-2, 582.

6. Reeve VE, Allanson M, Arun SJ, Domanski D, Painter N. Mice drinking goji berry juice (Lycium barbarum) are protected from UV radiation-induced skin damage via antioxidant pathways. Photochem Photobiol Sci. 2010;9:601-7.

7. Cao GW, Yang WG, Du P. [Observation of the effects of LAK/IL-2 therapy combining with Lycium barbarum polysaccharides in the treatment of 75 cancer patients]. Zhonghua Zhong.Liu Za Zhi. 1994;16:428-31.

8. Li G, Sepkovic DW, Bradlow HL, Telang NT, Wong GY. Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism. Nutr Cancer. 2009;61:408-14.

9. Amagase H, Nance DM. A randomized, double-blind, placebo-controlled, clinical study of the general effects of a standardized Lycium barbarum (Goji) Juice, GoChi. J Altern Complement Med. 2008 May;14:403-12.

10. Amagase H, Sun B, Borek C. Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in serum of healthy adults. Nutr Res. 2009;29:19-25.

11. Amagase H, Sun B, Nance DM. Immunomodulatory effects of a standardized Lycium barbarum fruit juice in Chinese older healthy human subjects. J Med Food. 2009;12:1159-65.

12. Xin YF, Zhou GL, Deng ZY, et al. Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity. Phytother Res. 2007;21:1020-4.

13. Lam AY, Elmer GW, Mohutsky MA. Possible interaction between warfarin and Lycium barbarum L. Ann.Pharmacother. 2001;35:1199-201.

14. Leung H, Hung A, Hui AC, Chan TY. Warfarin overdose due to the possible effects of Lycium barbarum L. Food Chem Toxicol. 2008;46:1860-2.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy